Inlyta Európai Unió - magyar - EMA (European Medicines Agency)

inlyta

pfizer europe ma eeig  - axiti - karcinóma, vese sejt - a protein kináz inhibitorok - inlyta is indicated for the treatment of adult patients with advanced renal cell carcinoma (rcc) after failure of prior treatment with sunitinib or a cytokine.